Business ❯ Finance ❯ Corporate Finance ❯ Profitability

Quarterly Earnings

Dupixent Powers Sanofi’s Q3 as Vaccine Sales Slip

Record Dupixent sales cushioned weaker vaccines to keep full‑year guidance intact.

Ryder Posts Q3 EPS Beat as Revenue Stalls, Shares Slide on Narrowed Guidance